The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VXM01 phase I study in patients with progressive glioblastoma: Final results.
 
Wolfgang Wick
Honoraria - MSD Oncology
Consulting or Advisory Role - Celldex; Roche/Genentech
Research Funding - Apogenix (Inst); Boehringer Ingelheim (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Antje Wick
No Relationships to Disclose
 
Felix Sahm
No Relationships to Disclose
 
Dennis Riehl
No Relationships to Disclose
 
Andreas von Deimling
Research Funding - Bayer
Patents, Royalties, Other Intellectual Property - Patent for BRAFV600E antibody VE1 administered by the German Cancer Center (DKFZ); Patent for IDH1R132H antibody H09 administered by the German Cancer Center (DKFZ)
Travel, Accommodations, Expenses - Roche
 
Martin Bendszus
No Relationships to Disclose
 
Philipp Kickingereder
No Relationships to Disclose
 
Philipp Beckhove
Research Funding - VAXIMM (Inst)
Patents, Royalties, Other Intellectual Property - Bayer (Inst); Iomx (Inst)
Travel, Accommodations, Expenses - BMS Brazil; Roche
 
Friedrich Hubertus Schmitz-Winnenthal
Honoraria - VAXIMM
Consulting or Advisory Role - VAXIMM
Research Funding - VAXIMM
Travel, Accommodations, Expenses - VAXIMM
 
Christine Jungk
No Relationships to Disclose
 
Sébastien Wieckowski
Employment - VAXIMM
 
Lilli Podola
Employment - VAXIMM
Stock and Other Ownership Interests - VAXIMM
 
Christel Herold-Mende
No Relationships to Disclose
 
Andreas Unterberg
No Relationships to Disclose
 
Michael Platten
Honoraria - Merck; Novartis; Roche
Consulting or Advisory Role - Bayer (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst)
Research Funding - Bayer (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Diagnosing and treating IDH1-mutant cancers; Treating cancers with AHR antagonists; Treating H3.3K27M-mutant cancers
Travel, Accommodations, Expenses - Merck; Novartis; Roche